Skip to main content
OpenTrials
Completed

NCT Number: NCT05235412

A Cohort Study on Milk Composition, Health Outcomes, and Feeding Practices of Chinese Mothers and Infants

This is a cohort study to understand the changes of breastmilk composition in the first six months after birth of Chinese infants.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Nanjing Medical University Jiangning Campus

Nanjing, Jiangsu, 211166, China

About this study

The relationship of breastmilk composition, the maternal gut microbiome and lifestyle factors such as diet, feeding practices and physical activity and the infant's health and gut microbiome will be investigated in this study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Mothers:

  • Generally healthy mothers with the intention to breastfeed.
  • Aged 18 years and above.
  • Written informed consent.

Infants:

  • Generally healthy term born (gestational age between 37 and 42 weeks).
  • Breastfed by their mothers, either exclusively or in combination with infant milk formula, at enrolment.
  • Chinese ethnicity of mother and father.

Exclusion criteria

Mothers:

  • Participation in any other studies involving investigational or marketed products concomitantly or two weeks prior to entry into the study.
  • Difficulty to follow up and/or locate (e.g. known transfer to other hospitals, residing outside the city where the study site is located, or planning to move out of the current city; incapability of mothers to comply with study protocol or investigator' s uncertainty about the willingness or ability of the mothers to understand and comply with the protocol requirements.
  • Illegal drug use.
  • Regular smoking and/ or consumption of alcoholic beverages as per investigator's judgement.
  • A BMI of <18.5 or ≥ 28 pre-pregnancy or during the first regular pregnancy check around or before 16 weeks of gestational age.
  • Acute infectious disease or neoplastic disease or any kind of weakening or debilitating conditions (with history of positive, hepatitis C virus (HCV) or HIV serological test at any time during the pregnancy).
  • Presence of mastitis, fungal infections of the nipple or areola; reactivation of herpes simplex (HSV) or varicella zoster infection in the mammary or thoracic region at the time of enrolment.
  • Presence of chronic diseases such as endocrine, cardiovascular, renal, respiratory or hepatic diseases.
  • Presence of psychosis and severe post-partum depression.
  • Presence of autoimmune disease such as systemic lupus erythematosus, systemic scleroderma, ulcerative colitis, Crohn's disease, celiac disease.
  • Women whose health condition, according to the investigator's judgement, could interfere with the study conduction and assessment.
  • Mothers who have given birth to twins or multiples or infant conceived with Assisted Reproductive Technology (ART).

Infants:

  • Participation in any other studies involving investigational or marketed products concomitantly or two weeks prior to entry into the study.
  • At enrolment, any congenital abnormality, chromosomal disorder or severe disease which could interfere with the study conduct and assessment.
  • Consumption of food other than breast milk or infant formula.
  • Fully formula fed at enrolment.

Treatment and study plan

Not applicable: Observational study without any interventions.

Other

Exposures of interest: Maternal diet and lifestyle, demographics, anthropometrics, infant's health outcomes

Primary outcomes

  1. Changes in human milk protein concentration

    Time frame: Human milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birth

    Protein concentration in g/l of human milk will be analyzed

  2. Changes in human milk fat concentration

    Time frame: Human milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birth

    Fat concentration in g/l of human milk will be analyzed

  3. Changes in human milk carbohydrate concentration

    Time frame: Human milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birth

    Carbohydrate concentration in g/l of human milk will be analyzed

  4. Changes in human milk energy content

    Time frame: Human milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birth

    Energy content in kCal/l of human milk will be analyzed

  5. Changes in infant length

    Time frame: Anthropometrics collected at birth, and 1 month, 3 month, 6 months, 12 months, 2 years after infant birth

    Length measured in cm

  6. Changes in infant head circumference

    Time frame: Anthropometrics collected at birth, and 1 month, 3 month, 6 months, 12 months, 2 years after infant birth

    Head circumference measured in cm

  7. Changes in infant weight

    Time frame: Anthropometrics collected at birth, and 1 month, 3 month, 6 months, 12 months, 2 years after infant birth

    Weight measured in grams

Secondary outcomes

  1. Variations in human milk microbiome

    Time frame: Human milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birth

    Analyzed by sequencing

  2. Variations in human milk micronutrients

    Time frame: Human milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birth

    Analyzed by mass spectrometry

  3. Variations in human milk oligosaccharides (HMOs)

    Time frame: Human milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birth

    Analyzed by mass spectrometry

  4. Variations in human milk lipid composition

    Time frame: Human milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birth

    Analyzed by mass spectrometry

  5. Variations in human milk amino acids and proteins

    Time frame: Human milk samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birth

    Analyzed by mass spectrometry

  6. Variations in infant fecal microbiome

    Time frame: Infant fecal samples collected at 1 month, 3 month, 6 months, 12 months, 2 years after infant birth

    Analyzed by sequencing

  7. Variations in maternal fecal microbiome

    Time frame: Maternal fecal samples collected at 1 month, 3 month, 6 months, 12 months after infant birth

    Analyzed by sequencing

  8. Changes in infant stool consistency and frequency

    Time frame: Data collected at 1 month, 3 month, 6 months, 12 months after infant birth

    Data will be collected via diaries using the Brussel Infant and Toddler Stool Scale

  9. Changes in infant feeding practices

    Time frame: Data collected at 1 month, 3 month, 6 months, 12 months,2 years after infant birth

    Dietary data will be collected via questionnaires

  10. Changes in maternal body mass index

    Time frame: Data collected at 1 month, 3 month, 6 months, 12 months 2 years after infant birth

    Maternal weight and height will be combined to determine body mass index [kg/m2]

Sponsors and collaborators

Lead sponsor

Danone Nutricia

Industry

Registry information

Acronym: Phoenix

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
Feb 11, 2022
Registry last updated
Dec 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.